Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Hemodynamic Effects of Physiotherapy in the Early Postoperative Period

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03726541
Recruitment Status : Completed
First Posted : October 31, 2018
Last Update Posted : March 7, 2019
Sponsor:
Information provided by (Responsible Party):
esra pehlivan, Istanbul Medipol University Hospital

Brief Summary:
Physiotherapy will be applied to the patients who undergo thoracotomy operation after 24 hours of intensive care stay. Physiotherapy program includes breathing exercises, incentive spirometer training, ambulation. Oxygen saturation, heart rate and blood pressure values will be recorded before and after the training session. Changes in the follow-up parameters will be discussed.

Condition or disease Intervention/treatment Phase
Physiotherapy Postoperative Lung Diseases Other: physiotherapy Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 72 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Official Title: Hemodynamic Effects of Physiotherapy in the Early Postoperative Period
Actual Study Start Date : November 1, 2018
Actual Primary Completion Date : December 30, 2018
Actual Study Completion Date : December 30, 2018

Arm Intervention/treatment
Experimental: Early physiotherapy group
breathing exercise incentive spirometry training ambulation coughing
Other: physiotherapy
Physiotherapy program includes breathing exercises, incisive spirometer study, grade ambulation. Oxygen saturation, heart rate and blood pressure values will be recorded before and after the session. Changes in the follow-up parameters will be discussed.




Primary Outcome Measures :
  1. Change from baseline oxygen saturation [ Time Frame: 30 minutes ]
    The hearth rate response will be measured before and after exercise training with pulse oximeter.

  2. Change from baseline hearth rate response. [ Time Frame: 30 minutes ]
    The hearth rate response will be measured before and after exercise training with intensive care ECG

  3. Change from baseline systolic and diastolic blood pressure response. [ Time Frame: 30 minutes ]
    Blood pressure will be measured before and after exercise training with monometer from the arm



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria

  • Between 18-75 age
  • Hemodynamically stable
  • Being conscious

Exclusion Criteria:

  • Excessive pain
  • Neurological complications
  • Posttraumatic and musculoskeletal problems to prevent exercise
  • Do not want to be included in the study
  • Fever above 38 degrees

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03726541


Locations
Layout table for location information
Turkey
Yedikule Chest Disease Hospital
Istanbul, Zeytinburnu, Turkey, 34200
Sponsors and Collaborators
Istanbul Medipol University Hospital
Investigators
Layout table for investigator information
Study Chair: Arif Balcı Saglik Bilimleri Universitesi

Layout table for additonal information
Responsible Party: esra pehlivan, Principal investigator, Istanbul Medipol University Hospital
ClinicalTrials.gov Identifier: NCT03726541    
Other Study ID Numbers: Hemodynamics_ physiotherapy
First Posted: October 31, 2018    Key Record Dates
Last Update Posted: March 7, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Respiratory Tract Diseases